Initially, CCDC3 mRNA level was found to be induced upon INZ treatment of p53+/+ HCT116 colon cancer cells (Supplementary Fig. 1a), suggesting that CCDC3 might be a potential p53 target. This evidence concerns the gene TP53 and malignant colon neoplasm.